실시간 PCR, 디지털 PCR 및 엔드포인트 PCR 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Real-time PCR, Digital PCR, And End-point PCR Market size is expected to reach USD 13.07 Billion in 2034 from USD 8.90 Billion (2025) growing at a CAGR of 4.36% during 2026-2034.

The global real-time PCR, digital PCR, and end-point PCR market is growing rapidly due to increasing demand for advanced molecular diagnostics. Rising prevalence of infectious diseases, genetic disorders, and cancer has boosted the need for accurate and early detection technologies. PCR techniques are widely used in clinical diagnostics, research laboratories, and forensic applications.

Technological advancements have improved sensitivity, accuracy, and speed of PCR-based testing. Growing investments in biotechnology research and expanding applications in personalized medicine further drive market growth. Increased awareness about early disease diagnosis and improved healthcare infrastructure globally also support expansion.

Looking forward, the market is expected to witness strong innovation in automated and portable PCR systems. Expansion of genomics research and growing adoption of precision medicine will enhance demand. Emerging markets are anticipated to provide significant growth opportunities due to increasing healthcare spending and laboratory modernization.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Quantitative
• Digital
• End-point

By Product

• Consumables & Reagents
• Instruments
• Software & Services

By Application

• Clinical
• Research
• Forensic

COMPANIES PROFILED

• Abbott, Qiagen, BioRad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Healthcare, bioMrieux, F HoffmannLa Roche Ltd, Fluidigm Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Quantitative Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Digital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. End-point Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Consumables & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Product
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Product
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Product
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Product
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Product
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott
  • 9.2.2 Qiagen
  • 9.2.3 Bio-Rad Laboratories Inc
  • 9.2.4 Agilent Technologies Inc
  • 9.2.5 Thermo Fisher Scientific Inc
  • 9.2.6 GE Healthcare
  • 9.2.7 BioMAfA(C)Rieux
  • 9.2.8 F. Hoffmann-La Roche Ltd
  • 9.2.9 Fluidigm Corporation